首发精神分裂症患者同型半胱氨酸水平和骨代谢标志物相关性研究

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (0 KB) HTML (38 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the correlation between homocysteine (HCY) level and bone metabolic markers in patients with first-episode schizophrenia.Methods A total of 69 patients with first-episode schizophrenia who were admitted to Zhongshan Third People′s Hospital from May 2016 to April 2020 were selected as the research objects according to the International Classification of Diseases 10th edition Mental and Behavioral Disorders. Patients were divided into high HCY group (HCY>15.4 μmol/L, with 31 cases) and normal HCY group (HCY≤15.4 μmol/L, with 38 cases) according to the HCY level of patients.General data,HCY,bone metabolism markers(osteocalcin[OCN], β-collagen breakdown product [β-CTX], 25-hydroxy vitamin D [VitD-T], procollagen type ⅠN propeptide [PⅠNP] and parathyroid hormone [PTH]) and cerebrovascular-related indexes (triacylglycerol [TG], total cholesterol [TC], high-sensitivity C-reactive protein [hs-CRP], high-density lipoprotein [HDL], low density lipoprotein [LDL], creatine kinase [CK], creatine kinase isoenzyme [CK-MB]) in the two groups were collected, and their differences and correlation were analyzed. Results The levels of CK, CK-MB and PⅠNP in the high HCY group were higher than those in the normal HCY group, and the differences were statistically significant (P<0.05). There were no significant differences in the levels of hs-CRP, TG, TC,HDL, OCN, β-CTX, VitD-T, PTH and LDL between the two groups (P>0.05). Correlation analysis showed that HCY level was positively correlated with CK, CK-MB and HDL levels in schizophrenia patients (P<0.05). HCY was positively correlated with PⅠNP (P<0.05). Conclusion HCY level has a certain correlation with bone metabolism markers in patients with first-episode schizophrenia, and also has a certain correlation with cerebrovascular-related indexes.

Key words： Schizophrenia;Homocysteine;Bone metabolism markers Difference Correlation

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WU Yong
	WAN Jing
	PING Jun-jiao
	HUANG Cai-ying
	DU Qi-feng
	DU Bao-guo

Cite this article:

WU Yong,WAN Jing,PING Jun-jiao, et al. Study on the correlation between homocysteine level and bone metabolism markers in patients with fist-episode schizophrenia[J]. 中国当代医药, 2021, 28(16): 82-85.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I16/82

[1]	Howard L，Kirkwood G，Leese M.Risk of hip fracture in patients with a history of schizophrenia[J].Br J Psychiatry，2007，190：129-134.
[2]	Kishimoto T，De Hert M，Carlson HE，et al.Osteoporosis and fracture risk in people with schizophrenia[J].Curr Opin Psychiatry，2012，25（5）：415-429.
[3]	Kishimoto T，Watanabe K，Takeuchi H，et al.Bone mineral density measurement in female in patients with schizophrenia[J].Schizophr Res，2005，77（1）：113-115.
[4]	Agorastos A，Weinas A，Agorastos AD，et al.Psychosis-induced vitamin D deficiency with secondary hyperparathyroidism and osteoporotic fracture[J].Gen Hosp Psychiatry，2011，33（6）：641-645.
[5]	McGrath JJ，Bume TH，Feron F，et al.Developmental vitamin D deficiency and risk of schizophrenia：a 10-year update[J].Schizophr Bull，2010，36（6）：1073-1078.
[6]	Eriksson R，Broberg BV，Ishoy PL，et al.Bone Status in Obese，Non-diabetic，Antipsychotic-Treated Patients，and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density[J].Front Psychiatry，2019，9：781-787.
[7]	吴勇，平军娇，杜宝国，等.非典型抗精神病药对精神分裂症患者骨代谢的影响[J].临床精神医学杂志，2017，27（4）：272-274.
[8]	梁英，于欣.抗精神病药物对精神分裂症患者骨密度影响的研究进展[J].国际精神病学，2014，41（2）：116-118.
[9]	吴勇，万静，平军娇，等.精神分裂症患者骨代谢标志物的研究[J].中国当代医药，2018，25（3）：120-122.
[10]	Moshal KS，Singh M，Sen U，et al.Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC[J].Am J Physiol Heart Circ Physiol，2006，291（6）：H2825-H2835.
[11]	World Health Organization.ICD-10 精神与行为障碍分类[M].范肖冬，汪向东，于欣，等.北京：人民卫生出版社，1993：72-79.
[12]	Sharif PS，Abdollahi M.The role of platelets in bone remodeling[J].Inflamm Allergy Drug Targets，2010，9（5）：393-399.
[13]	Salari P，Larijani B，Abdollahi M.Association of hyperhomocysteinemia with osteoporosis：a systematic review[J].Therapy，2008，5（2）：215-222.
[14]	Seshadri S，Beiser A，Selhub J，et al.Plasma homocysteine as a risk factor for dementia and Alzheimer′s disease[J].N Engl J Med，2002，346（7）：476-478.
[15]	Vacek TP，Kalani A，Voor MJ，et al.The role of homocysteine in bone remodeling[J].Clin Chem Lab Med，2013，51（3）：579-590.
[16]	Tyagi N，Kandel M，Munjal C，et al.Homocysteine mediated decrease in bone blood flow and remodeling：role of folic acid[J].J orthop Rep，2011，29（10）：1511-1516.
[17]	McLean RR，Jacques PF，Selhub J，et al.Homocysteine as a predictive factor for hip fracture in older persons[J].N Engl J Med，2004，350（20）：2042-2049.
[18]	Gjesdal CG，Vollset SE，Ueland PM，et al.Plasma total homocysteine level and bone mineral density：the Hordaland Homocysteine Study[J].Arch Intern Med，2006，166（1）：88-94.
[19]	石莹，姬晓炜，李晶，等.脂代谢紊乱患者牙种植体稳定性的评价[J].中国医科大学学报，2017，46（3）：251-254.
[20]	Ogata M，Ide R，Takizawa M，et al.Association between basal metabolic function and bone metabolism in postmenopausal women with type 2 diabetes[J].Nutrition，2015，31（11-12）：1394-140l.
[21]	李裕明，廖云飞，袁唯唯．内分泌性骨质疏松症[J].临床内科杂志，2016，33（9）：58l-584.
[22]	孔晶，邢小平.糖尿病与骨质疏松症[J].临床内科杂志，2016，33（9）：585-588.
[23]	Rubin MR，Goldfine AB，McMahon DJ，et al.Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus[J].Endocrine，2015，50（2）：504-507.
[24]	张萌萌，张秀珍，邓伟民.骨代谢生化指标临床应用专家共识（2020）[J].中国骨质疏松杂志，2020，26（6）：781-796.
[25]	Krege JH，Lane NE，Harris JM，et al.PINP as a biological response marker during teriparatide treatment for osteoporosis[J].Osteoporos Int，2014，25（9）：2159-2171.